Soluble CD95 Ligand Role in the Pathophysiology of Antineutrophil Cytoplasmic Antibody (ANCA) Associated Vasculitis
Clinical trial NCT03698071 · COMPLETED
Trial details
- NCT number
- NCT03698071
- Sponsor
- University Hospital, Bordeaux
- Status
- COMPLETED
- Phase
- Not Applicable
- Study type
- INTERVENTIONAL
- Start date
- 2018-12-14
- Primary completion
- 2024-09-18
- Enrollment
- 48
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.